Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Topic Tracks*:

Organ Site Tracks*:

Showing session: reset

Clinical Trials of Combinations of Molecularly Targeted and Non-targeted Therapeutic Agents

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 8 of 8
Final biomarker analysis of the phase I study of the selective BRAF V600 inhibitor encorafenib (LGX818) combined with cetuximab with or without the α-specific PI3K inhibitor alpelisib (BYL719) in patients with advanced BRAF-mutant colorectal cancer
Jan H. M. Schellens
The Netherlands Cancer Institute, Amsterdam, Netherlands
from AACR Annual Meeting 2015 on April 19, 2015 3:15 PM-5:15 PM
Discussant
Jordan D. Berlin
Vanderbilt-Ingram Cancer Center, Nashville, TN, United States
from AACR Annual Meeting 2015 on April 19, 2015 3:15 PM-5:15 PM
Translating preclinical observations to the clinic: Combination of the dual m-TORC1/2 inhibitor AZD2014 and paclitaxel in ovarian and lung cancer
Udai Banerji
Inst. of Cancer Research and The Royal Marsden, London, United Kingdom
from AACR Annual Meeting 2015 on April 19, 2015 3:15 PM-5:15 PM
Discussant
Philippe L Bedard
Univ. of Toronto Univ. Health Network, Toronto, ON, Canada
from AACR Annual Meeting 2015 on April 19, 2015 3:15 PM-5:15 PM
Phase I study of GDC-0425, a checkpoint kinase 1 inhibitor, in combination with gemcitabine in patients with refractory solid tumors
Jeffrey R. Infante
Sarah Cannon Research Institute, Nashville, TN, United States
from AACR Annual Meeting 2015 on April 19, 2015 3:15 PM-5:15 PM
Discussant
Gary K. Schwartz
Columbia University Irving Comp. Cancer Center, New York, NY, United States
from AACR Annual Meeting 2015 on April 19, 2015 3:15 PM-5:15 PM
Combination of agonistic CD40 monoclonal antibody CP-870,893 and anti-CTLA-4 antibody tremelimumab in patients with metastatic melanoma
David L Bajor
University of Pennsylvania, Philadelphia, PA, United States
from AACR Annual Meeting 2015 on April 19, 2015 3:15 PM-5:15 PM
Discussant
Paul B. Chapman
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2015 on April 19, 2015 3:15 PM-5:15 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 8 of 8